Clinical practice guidelines lack value-conscious considerations

Most medical societies urge their clinical-guidance developers to include cost data alongside care recommendations. Yet less than a quarter of published advisements—22.5%—contain evidence-based discussions on economic considerations or resource consumption. 

The findings are from a study conducted at Yale and published in JAMA Network Open June 26. 

Lead author Anand Habib, MD, MPhil, MHS, senior author Joseph Ross, MD, MHS, and colleagues further found a mere 3.8% of medical-society guidelines had upfront economic or resource use–related recommendation statements.

For the research, the team analyzed manuals instructing guidance developers at 23 large, U.S.-based medical societies. 

Per the 23 societies’ guidance-development manuals, some 14 societies (60.9%) explicitly suggested that economic or resource use–related evidence be considered. 

Yet only 1,706 of 7,582 resulting recommendations—the 22.5% noted above—included cost-conscious considerations. 

Meanwhile six of 23 development manuals (26.1%) “ambiguously addressed” the approach, and three (13.0%) never addressed it at all.

Value is where the actions make good on the words  

In their discussion section, Habib and co-authors note U.S. healthcare’s ongoing call for keeping the value in “value-based” care. 

They underscore two points from their primary findings:  

  • Recommendations issued by societies that, according to their CPG methods manuals, explicitly suggested that economic or resource use–related evidence be considered had 6-fold greater odds of discussing such evidence but did not demonstrate greater odds of providing upfront economic or resource use–related statements. 
     
  • By contrast, although primary care societies’ recommendations did not have greater odds of discussing economic or resource use–related evidence, they had nearly 13-fold higher odds of providing upfront economic or resource use–related recommendation statements.

A clear path forward emerges 

“With $100 billion in healthcare expenditures arising from low-value care and 4 of 5 physicians eager to follow value-based care recommendations within clinical practice guidelines, societies may be increasingly recognizing the relevance of economic or resource use–related considerations,” the authors remark. 

With higher quality health-economic evidence and societies clarifying how they appraise such evidence, they add, medical societies’ clinical practice guidelines “could better inform value-based care amidst rising healthcare costs.”

The study is posted in full for free

 

Subscribe to Health Exec News

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Subscribe to Health Exec News

Subscribe to Health Exec News